Cell Death & Disease http://feeds.nature.com/cddis/rss/current Nature Publishing Group en © 2025 Macmillan Publishers Limited, part of Springer Nature. All rights reserved. Cell Death & Disease © 2025 Macmillan Publishers Limited, part of Springer Nature. All rights reserved. [email protected]
  • Cell Death & Disease https://www.nature.com/uploads/product/cddis/rss.gif http://feeds.nature.com/cddis/rss/current <![CDATA[YTHDC2 suppresses bladder cancer by inhibiting SOX2-mediated tumor plasticity]]> https://www.nature.com/articles/s41419-025-08079-w <![CDATA[
    See More

    Cell Death & Disease, Published online: 27 October 2025; doi:10.1038/s41419-025-08079-w

    YTHDC2 suppresses bladder cancer by inhibiting SOX2-mediated tumor plasticity]]> <![CDATA[YTHDC2 suppresses bladder cancer by inhibiting SOX2-mediated tumor plasticity]]> Yi CaiCong ZhuMing-Hui ShiJin-Hui ZhangShu-Yan LiuJin-Long CuiMeng-Meng GuoDao-Jing MingXian-Tao ZengShuai YuanHong Weng doi:10.1038/s41419-025-08079-w Cell Death & Disease, Published online: 2025-10-27; | doi:10.1038/s41419-025-08079-w 2025-10-27 Cell Death & Disease 10.1038/s41419-025-08079-w https://www.nature.com/articles/s41419-025-08079-w <![CDATA[Ubiquitin-specific protease 7 regulates macrophage polarization via pyruvate kinase M2-mediated metabolic reprogramming in severe acute pancreatitis]]> https://www.nature.com/articles/s41419-025-08081-2 <![CDATA[

    Cell Death & Disease, Published online: 27 October 2025; doi:10.1038/s41419-025-08081-2

    Ubiquitin-specific protease 7 regulates macrophage polarization via pyruvate kinase M2-mediated metabolic reprogramming in severe acute pancreatitis]]>     <![CDATA[Ubiquitin-specific protease 7 regulates macrophage polarization via pyruvate kinase M2-mediated metabolic reprogramming in severe acute pancreatitis]]> Yao WuXudong YaoQiang YuQingqing YanXin HuangHuajing KeChao PengLiang Xia doi:10.1038/s41419-025-08081-2 Cell Death & Disease, Published online: 2025-10-27; | doi:10.1038/s41419-025-08081-2 2025-10-27 Cell Death & Disease 10.1038/s41419-025-08081-2 https://www.nature.com/articles/s41419-025-08081-2     <![CDATA[Hypoxia-induced exosomal LUCAT1 promotes osimertinib resistance in lung adenocarcinoma by stabilizing c-MET]]> https://www.nature.com/articles/s41419-025-08100-2 <![CDATA[

    Cell Death & Disease, Published online: 27 October 2025; doi:10.1038/s41419-025-08100-2

    Hypoxia-induced exosomal LUCAT1 promotes osimertinib resistance in lung adenocarcinoma by stabilizing c-MET]]>     <![CDATA[Hypoxia-induced exosomal LUCAT1 promotes osimertinib resistance in lung adenocarcinoma by stabilizing c-MET]]> Jianting DuBin ZhengJiekun QianGuanglei HuangWenjie YuanRenjie HuangXian GongGuobing XuBixing ZhaoXiaolong LiuYingchao WangZhang YangChun Chen doi:10.1038/s41419-025-08100-2 Cell Death & Disease, Published online: 2025-10-27; | doi:10.1038/s41419-025-08100-2 2025-10-27 Cell Death & Disease 10.1038/s41419-025-08100-2 https://www.nature.com/articles/s41419-025-08100-2     <![CDATA[Chemotherapy enhances HMGA1 secretion through the mutant p53-CK2 axis in pancreatic ductal adenocarcinoma cells]]> https://www.nature.com/articles/s41419-025-08082-1 <![CDATA[

    Cell Death & Disease, Published online: 27 October 2025; doi:10.1038/s41419-025-08082-1

    Chemotherapy enhances HMGA1 secretion through the mutant p53-CK2 axis in pancreatic ductal adenocarcinoma cells]]>     <![CDATA[Chemotherapy enhances HMGA1 secretion through the mutant p53-CK2 axis in pancreatic ductal adenocarcinoma cells]]> Federica DanziGiovanna ButeraDamien SuttonMatthew D. PerriconeYushu HuAdriana CelesiaMarcello ManfrediJessica BrandiNarges PourmandiNoah S. NelsonLin LinMichele BevereRaffaella PacchianaAntonio PeaRoberto SalviaAldo ScarpaClaudio LuchiniDaniela CecconiStefano UgelCostas A. LyssiotisAlessandra FioreMassimo Donadelli doi:10.1038/s41419-025-08082-1 Cell Death & Disease, Published online: 2025-10-27; | doi:10.1038/s41419-025-08082-1 2025-10-27 Cell Death & Disease 10.1038/s41419-025-08082-1 https://www.nature.com/articles/s41419-025-08082-1     <![CDATA[Impairment of lysosomal quality control in Huntington disease]]> https://www.nature.com/articles/s41419-025-08103-z <![CDATA[

    Cell Death & Disease, Published online: 27 October 2025; doi:10.1038/s41419-025-08103-z

    Impairment of lysosomal quality control in Huntington disease]]>     <![CDATA[Impairment of lysosomal quality control in Huntington disease]]> Paola RusminiFrancesco MinaMarta ValenzaMartina VitaliVeronica FerrariBarbara TedescoElena CasarottoMarta CozziMarta ChierichettiAli MohamedPaola PramaggioreLaura CornaggiaCarmelo MiliotoMaria BrodnanovaRocio MagdalenaPrashant KoshalMargherita PiccolellaRiccardo CristofaniMariarita GalbiatiValeria CrippaAngelo Poletti doi:10.1038/s41419-025-08103-z Cell Death & Disease, Published online: 2025-10-27; | doi:10.1038/s41419-025-08103-z 2025-10-27 Cell Death & Disease 10.1038/s41419-025-08103-z https://www.nature.com/articles/s41419-025-08103-z     <![CDATA[<i>TRIM17</i> promotes the progression of osteosarcoma by regulating <i>PDK1</i> m6A modification-mediated <i>AKT/mTOR</i> pathway activation through ubiquitination of <i>FTO</i>]]> https://www.nature.com/articles/s41419-025-08070-5 <![CDATA[

    Cell Death & Disease, Published online: 27 October 2025; doi:10.1038/s41419-025-08070-5

    TRIM17 promotes the progression of osteosarcoma by regulating PDK1 m6A modification-mediated AKT/mTOR pathway activation through ubiquitination of FTO]]>     <![CDATA[<i>TRIM17</i> promotes the progression of osteosarcoma by regulating <i>PDK1</i> m6A modification-mediated <i>AKT/mTOR</i> pathway activation through ubiquitination of <i>FTO</i>]]> Wenda LiuDi ZhengXinghan HuangZhun WeiZicheng WeiWeichun Guo doi:10.1038/s41419-025-08070-5 Cell Death & Disease, Published online: 2025-10-27; | doi:10.1038/s41419-025-08070-5 2025-10-27 Cell Death & Disease 10.1038/s41419-025-08070-5 https://www.nature.com/articles/s41419-025-08070-5     <![CDATA[Targeting STAU1 prevents p53 apoptotic signaling in neurodegeneration]]> https://www.nature.com/articles/s41419-025-08067-0 <![CDATA[

    Cell Death & Disease, Published online: 27 October 2025; doi:10.1038/s41419-025-08067-0

    Targeting STAU1 prevents p53 apoptotic signaling in neurodegeneration]]>     <![CDATA[Targeting STAU1 prevents p53 apoptotic signaling in neurodegeneration]]> Mandi GandelmanSharan PaulKarla P. FigueroaJustine SundrudWarunee DansithongDaniel R. ScolesStefan M. Pulst doi:10.1038/s41419-025-08067-0 Cell Death & Disease, Published online: 2025-10-27; | doi:10.1038/s41419-025-08067-0 2025-10-27 Cell Death & Disease 10.1038/s41419-025-08067-0 https://www.nature.com/articles/s41419-025-08067-0     <![CDATA[TM9SF1 drives the lipophagic flux via AMPK-ULK1 signaling to sustain metabolic fitness in HER2-positive breast cancer]]> https://www.nature.com/articles/s41419-025-08093-y <![CDATA[

    Cell Death & Disease, Published online: 24 October 2025; doi:10.1038/s41419-025-08093-y

    TM9SF1 drives the lipophagic flux via AMPK-ULK1 signaling to sustain metabolic fitness in HER2-positive breast cancer]]>     <![CDATA[TM9SF1 drives the lipophagic flux via AMPK-ULK1 signaling to sustain metabolic fitness in HER2-positive breast cancer]]> Xiaofen LiXiaoqin YuKaiyan HuangXin YuShiping LuoXiewei HuangChuangui Song doi:10.1038/s41419-025-08093-y Cell Death & Disease, Published online: 2025-10-24; | doi:10.1038/s41419-025-08093-y 2025-10-24 Cell Death & Disease 10.1038/s41419-025-08093-y https://www.nature.com/articles/s41419-025-08093-y